Investing Profile

Bali Muralidhar

InvestorVC
Managing Partner at Abingworth
abingworth.com/team/bali-mura...London
Photo of Bali Muralidhar, Managing Partner at Abingworth
Your Intro Paths to Bali Muralidhar
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Bali Muralidhar on

cb
Current Investing Position
Abingworth Managing Partner
Investment Range
$15.0M - $30.0M
Sweet Spot
$22.5M
Investments On Record
10
Current Fund Size
$465M

Bali Muralidhar is on these Sector & Stage Rankings

Bali Muralidhar's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Ascend Gene & Cell Therapies
Series AMay 2023$66M
$66M
Anjarium Biosciences
Series ASep 2021$60M
$60M
CymaBay Therapeutics
Post Ipo DebtAug 2021$100M
$190M
Co-investors: Andrew Schwab (5am Ventures), Tony Evnin (Venrock)
Wugen
Series BJul 2021$170M
$170M
Co-investors: John McKearn (RiverVest)
Glycomine
Series BJun 2021$35M
$35M
Co-investors: Jim Trenkle (Sanofi Ventures), Niall O’Donnell (RiverVest)
Reneo Pharmaceuticals
Series BDec 2020$95M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)
NuCana BioMed
Post Ipo EquityOct 2020$80M
$140M
Co-investors: James Healy (Sofinnova Investments)
Spruce Biosciences
Series BFeb 2020$88M
$88M